US$ 26.31
maravai lifesciences holdings glp-1 receptor agonist medications A Comprehensive Review on the Pharmacokinetics and Drug−Drug Interactions of Approved Agonists and a Dual GLP-1/GIP Receptor The Landscape Of GLP-1 Receptor
Description
Larsen TM, Dalskov SM, van Baak M, Jebb SA, Papadaki A, Pfeiffer AF, et al

15 Additionally, the 2019 guidelines issued by the European Society of Cardiology and the EASD suggest using GLP1 RA as initial therapy in patients with type 2 diabetes and cardiovascular disease or those at high risk of cardiovascular disease (no class recommendation)

N Engl J Med 2022;387:20516.ArticlePubMed 27

Safer options include medically supervised GLP-1 therapy, nutritional counseling, cognitive behavioral therapy (CBT), dialectical behavior therapy (DBT), and holistic approaches like mindfulness-based stress reduction

As a result, GLP-1RAs display suppressive effects on mitochondrial functions and oxidative stress on heart failure [79]

42(Suppl 1):S88-S103
